Although global standards in clinical research excellence apply to all professionals across the globe, unfortunately not all professionals are able to actually work according to these standards due to e.g. their geographic location. Our patients will only benefit if we will exchange our knowledge and have open discussions to support genuine collaboration amongst all of us involved in clinical research.
In this webinar you will learn what you need to know about general considerations for clinical studies following recent international guideline updates. Speakers will also share their perspectives and experiences of clinical research excellence from across their field of research.
Dr Annalene Nel, Medinel cc, South Africa
Andy Lawton, Risk Management & Quality by Design Consultant
Dr Viviënne van de Walle, Society for Clinical Research Sites (SCRS) / PT&R, NL
Dr Kim Narunsky, University of Cape Town, Lung Institute
Gill Slater, Chair Pharmaceutical Contracts Management Group (PCMG)
It is recommended to read ICH guideline E8 (R1) on general considerations for clinical studies, but it is not mandatory. Visit: https://database.ich.org/sites/default/files/E8-R1_Guideline_Step4_2021_1006.pdf
This webinar is organised by the Global Health Clinical Consortium (GHCC), The Global Health Network (TGHN) and the Pharmaceutical Contract Management Group (PCMG).
The Global Health Clinical Consortium (GHCC) is a collaboration of Product Development Partners and preferred Contract Research Organisations focussed on combatting diseases that particularly affect the poorest.
The Global Health Network (TGHN) works across all aspects of health research to enable easier, faster, and better research in the world’s most challenging settings.
The Pharmaceutical Contract Management Group (PCMG) is a dedicated and unique association of clinical outsourcing and procurement professionals working in research and development functions across the pharmaceutical industry.